COVID-19 should be treated as a blood clot disease, new study shows
In a new study, researchers suggest that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary...
What does recovery from COVID-19 look like?
Yale Medicine physicians describe the recovery path they’ve seen for patients experiencing 'mild to moderate' forms of the disease.
The majority of COVID-19 cases can be...
These two anti-inflammatory drugs could stop growth of COVID-19 virus
In a new study, researchers found that a human and a veterinary anti-inflammatory drug—Carprofen and Celecoxib—inhibit a key enzyme in the replication and transcription...
This drug for alcoholism may offer hope for COVID-19 treatment
In a new study, researchers discovered that disulfiram, an FDA-approved drug commonly used for treating alcoholism, blocks a key gatekeeper protein involved in inflammation.
Activation...
Scientists find universally effective antibodies to fight COVID-19
In a new study, researchers report the first round of results from an immunological study of 149 people who have recovered from COVID-19.
They show...
Cloth masks may help prevent COVID-19 transmission, new study shows
In a new review study, researchers found that cloth masks, particularly those with several layers of cotton cloth, block droplet, and aerosol contamination of...
Dementia gene could double risk of severe COVID-19
In a new study, researchers found that having a faulty gene linked to dementia doubles the risk of developing severe COVID-19.
They found a high...
Why COVID-19 could make the overdose epidemic worse
When Alberta's chief medical officer, Deena Hinshaw, announced special exemptions to COVID-19 regulations for group therapy in residential addiction treatment centers, it was exactly...
Face coverings could effectively reduce COVID-19 transmission risk
In a new study, researchers found that wearing a face mask or other covering over the mouth and nose reduces the forward distance traveled...
Scientists find a promising drug to reduce lung inflammation in COVID-19
In a new study, researchers found that an experimental drug, leronlimab, may prevent the "cytokine storm" that inflames and fatally damages the lungs and...